Corindus Vascular Robotics (Natick, MA) won FDA clearance for its CorPath 200 System for performing robotic assisted coronary angioplasties.
Traditionally, clinicians are exposed to stray X-ray radiation from the C-arm as they guide instruments through a patient’s vasculature. The CorPath system allows the physician to work away from the patient by controlling instruments via a cool looking interface that seems like it’s out of a NASA program. Not only is the physician kept safely away from repeated radiation exposure, but patients may benefit if the robot improves surgeons’ dexterity and ability to control the instruments.
Precise robotic movement and device fixation
- Precise, robotic-assisted control allows placement of guidewire and catheter and stable device deployment
- Fixates and holds devices at all times
- Open architecture system allows users to select their own preferred guidewire, balloon and stent
Enhanced visualization and measurement capability
- Improves visualization of angiography
- Measurement capability within seconds
- Interventional lead-lined cockpit
- Radiation protection without the use of heavy lead apparel
- Reduces fatigue enabling better concentration and focus
- Comfortable seating position minimizes head, neck, and back strain due standing while wearing a lead apron
Press release: FDA CLEARS FIRST ROBOTIC-ASSISTED SYSTEM FOR CORONARY ARTERY DISEASE STENT
Product page: CorPath 200 System
Flashbacks: CorPath 200 Robotic Guidewire and Balloon/Stent Placement System Going to Trial; Philips Adding Corindus’ Percutaneous Coronary Intervention Robotics to Its Cardiology Solutions